Crude Model | Model 1 | Model 2a | ||||||
---|---|---|---|---|---|---|---|---|
Crude OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | |||
Presence of MetS | 2.77 (2.50, 3.07) | < 0.001 | 1.92 (1.70, 2.17) | < 0.001 | 1.96 (1.73, 2.22) | < 0.001 | ||
Central obesity | 2.32 (2.07, 2.59) | < 0.001 | 2.21 (1.92, 2.54) | < 0.001 | 2.42 (2.07, 2.82) | < 0.001 | ||
Hypertension | 2.35 (2.11, 2.61) | < 0.001 | 1.66 (1.44, 1.92) | < 0.001 | 1.40 (1.21, 1.63) | < 0.001 | ||
Hyperglycemia | 2.34 (2.11, 2.58) | < 0.001 | 1.50 (1.33, 1.70) | < 0.001 | 1.36 (1.20, 1.55) | < 0.001 | ||
Hypertriglyceridemia | 1.97 (1.76, 2.19) | < 0.001 | 1.24 (1.09, 1.41) | < 0.001 | 1.04 (0.91, 1.19) | 0.523 | ||
Dyslipidemia | 1.38 (1.24, 1.53) | < 0.001 | 1.26 (1.12, 1.43) | < 0.001 | 1.02 (0.90, 1.16) | 0.743 | ||
Per component increment | 1.44 (1.40, 1.50) | < 0.001 | 1.28 (1.22, 1.34) | < 0.001 | 1.32 (1.26, 1.38) | < 0.001 | ||
0 (ref) | ||||||||
1 | 1.50 (1.27, 1.78) | < 0.001 | 1.44 (1.19, 1.74) | < 0.001 | 1.60 (1.32, 1.94) | < 0.001 | ||
2 | 2.24 (1.90, 2.64) | < 0.001 | 1.84 (1.52, 2.24) | < 0.001 | 2.21 (1.81, 2.70) | < 0.001 | ||
3 | 3.34 (2.82, 3.95) | < 0.001 | 2.54 (2.07, 3.11) | < 0.001 | 3.03 (2.45, 3.75) | < 0.001 | ||
4 | 4.54 (3.76, 5.48) | < 0.001 | 2.76 (2.19, 3.48) | < 0.001 | 3.31 (2.60, 4.21) | < 0.001 | ||
5 | 5.64 (4.39, 7.26) | < 0.001 | 3.35 (2.48, 4.51) | < 0.001 | 3.80 (2.79, 5.16) | < 0.001 |